P97 Morel, S.; Landreau, A.; Nguyen, VH.; Derbré, S.; Grellier, P.; Le Pape, P.; Pagniez, F.; Litaudon, M.; Richomme, P. Preparative Isolation, Fast Centrifugal Partition Chromatography Purification and Biological Activity of Cajaflavanone from Derris ferruginea Stems. Phytochem. Anal., 2012, 23(2), 152-158.

P98 Antoine, M.; Gerlach, M.; Günther, E.; Schuster, T.; Czech, M.; Seipelt, I.; Marchand, P. A convenient synthesis of novel 2,8-disubstituted pyrido[3,4-b]pyrazines possessing biological activity. Synthesis, 2012, 44, 69-82. 

P99 Marhadour, S.; Bazin, M-A.; Marchand, P. An efficient access to 2,3-diarylimidazo[1,2-a]pyridines via imidazo[1,2-a]pyridine-2-yltriflate through a Suzuki cross-coupling reaction-direct arylation sequence. Tetrahedron Lett., 2012, 53, 297-300.

P100 Loidreau, Y.; Marchand, P.; Dubouilh-Benard, C.; Nourrisson, M-R.; Duflos, M.; Besson, T. First synthesis of 4-aminopyrido[2',3':4,5]furo[3,2-d]pyrimidines. Tetrahedron Lett., 2012, 53, 944-947.

P101 Morio, F.; Le Berre, J.-Y.; Garcia-Hermoso, D.; Najafzadeh, M.J.; de Hoog, S.; Benard, L.; Michau, C. Phaeohyphomycosis due to Exophiala xenobiotica as a cause of fungal arthritis in an HIV-infected patient. Med. Mycol., 2012, 50(3), 513-517.

P102 Robert, T.; Talarmin, J.-P.; Leterrier, M.; Cassagnau, E.; Le Pape, P.; Danner-Boucher, I.; Malard, O.; Brocard, A.; Gay-Andrieu, F.; Miegeville, M.; Morio, F. Phaeohyphomycosis due to Alternaria infectoria: a single-center experience with utility of PCR for diagnosis and species identification. Med. Mycol., 2012, 50(6), 594-600. 

P103 Morio, F.; Aubin, G.; Danner-Boucher, I.; Haloun, A.; Sacchetto, E.; Garcia-Hermoso, D.; Bretagne, S.; Miegeville, M.; Le Pape, P.  High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis. J. Antimicrob. Chemother., 2012, 67(8), 1870-1873.

P104 Morio, F.; Pagniez, F.; Lacroix, C.; Miegeville, M.; Le Pape, P. Amino acid substitutions in the Candida albicans sterol delta5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J. Antimicrob. Chemother., 2012, 67(9), 2131-2138.

P105 Alvarez-Rueda, N.; Albassier, M.; Allain, S.; Deknuydt, F.; Altare, F.; Le Pape, P. First Human Model of In Vitro Candida albicans Persistence within Granuloma for the Reliable Study of Host-Fungi Interactions. PLoS ONE, 2012, 7(6), e40185, 1-13.

P106 Bruel, A.; Logé, C.; de Tauzia, M.-L.; Ravache, M.; Le Guevel, R.; Guillouzo, C.; Lohier, J.-F.; Sopkova-de Oliveira Santos, J.; Lozach, O.; Meijer, L.; Ruchaud, S.; Bénédetti, H.; Robert, J.-M. Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3K inhibitors. Eur. J. Med. Chem., 2012, 57, 225-233.

P107 Loidreau, Y.; Marchand, P.; Dubouilh-Benard, C.; Nourrisson, M-R.; Duflos, M.; Lozach, O.; Loaec, N.; Meijer, L.; Besson, T. Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors. Eur. J. Med. Chem., 2012, 58, 171-183.

P108 Marhadour, S.; Marchand, P.; Pagniez, F.; Bazin, M.-A.; Picot, C.; Lozach, O.; Ruchaud, S.; Antoine, M.; Meijer, L.; Rachidi, N.; Le Pape, P. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents. Eur. J. Med. Chem., 2012, 58, 543-556.

P109 Dieng, Y.; Sow, D.; Ndiaye, M.; Guichet, E.; Faye, B.; Tine, R.; Lo, A.; Sylla, K.; Ndiaye, M.; Abiola, A.; Dieng, T.; Ndiaye, J.L.; Le Pape, P.; Gaye, O. Identification de trois souches de Candida africana au Sénégal. J. Mycol. Med., 2012, 22, 335-340.

P110 Malleter, M.; Jacquot, C.; Rousseau, B.; Tomasoni, C.; Jugé, M.; Pineau, A.; Sakanian, V.; Roussakis, C. miRNAs, a potential target in the treatment of Non-Small Cell Lung Carcinomas. Gene, 2012, 506, 355-9.

P111 Malleter, M.; Jacquot, C.; Rousseau, B.; Tomasoni, C.; Ducourneau, D.; Tourette, P.; Pineau, A.; Roussakis, C. Study of antiproliferative effects of synthetic substances against lens epithelial cell line (SRA01/04). J. Ocul. Pharmacol. Ther. 2012, 28, 299-306.